1) lymphocytotoxic crossmatch
淋巴毒试验
1.
Methods:Among 1 152 cases,550 cases received anti donor lymphocytotoxic crossmatch(LXM),335 cases received LXM and HLA serological test,267 cases of the latter again received panel reaction antibody(PRA)test, the change of the HAR rate with different HLA matching measures were analyzed.
方法 :115 2例肾移植中有 5 5 0例单纯行淋巴细胞毒抗体试验 (简称淋巴毒 ) ,335例行淋巴毒试验和 HL A血清学分型 ,在此基础上有 2 6 7例增加 PRA检测 ,观察每组超排发生率的变化。
2) Methods of micro-lymphocyte cytotoxic test
微量淋巴毒试验
3) LCT
淋巴细胞毒试验
1.
The relationship between ineffective platelet transfusion and LCT in hematologic malignancy;
恶性血液病患者血小板输注无效与淋巴细胞毒试验同种免疫的关系
4) lymphocyte cytotoxicity inhibition test
淋巴细胞毒抑制试验
5) inhibition of microlymphocytotoxicity method
微量淋巴细胞毒抑制试验
补充资料：淋巴细胞毒交叉配合试验
淋巴细胞毒交叉配合试验
lymphocyte cross matching
将含有细胞毒抗体的受者血清与供者的淋巴细胞加入补体后一起培养。受者血清中含有对抗供者淋巴细胞抗原HLA的抗体时，则两者结合后激活补体，损害供者淋巴细胞膜或引起细胞溶解。通过显微镜下观察死亡的淋巴细胞数量，可了解供受者之间的组织相容性。一般要求死亡细胞少于15%。若高于15%，移植后可能出现超急性排斥反应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条